Skip to main content

Table 2 BCLC Staging. Group I, patients who were diagnosed histologically; Group II, patients who were diagnosed radiologically

From: Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data

BCLC staging

Group I (n = 2920)

Group II (n = 5562)

Stage 0 (n, %)

169(5.8)

445(8.0)

Stage A (n, %)

1,455(49.8)

1,966(35.3)

Stage B (n, %)

277(9.5)

613(11.0)

Stage C (n, %)

674(23.1)

1,737(31.2)

Stage D (n, %)

47(1.6)

194(3.5)

Undefined (n, %)

298(10.2)

607(10.9)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us